Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Amy Dwyer

Group Leader

University of South Australia

Australia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Australia Professors in Cell Biology Cell Biology professors in Australia

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Carol A Lange

University of Minnesota

UNITED STATES

View details

Sally Wheelwright

University of Sussex

UNITED KINGDOM

View details

Geraldine Laven-Law

Flinders University

AUSTRALIA

View details

Caroline Diep, Ph.D.

Research Support, Research Professional 6

University of Minnesota

UNITED STATES

View details

Stefan Prekovic

Group leader

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Leila Hosseinzadeh

Université libre de Bruxelles (ULB)

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amy Dwyer

Research Interests

Make your next move.

Explore related searches

Articles (9)

Are androgen receptor agonists a treatment option in bladder cancer?

The transcription factor AP-2β defines active enhancers conferring molecular apocrine cell identity in breast cancer

The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer

Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial

Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer

Selective inhibition of CDK9 in triple negative breast cancer

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4

Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4&" (vol 164, bqad083, 2023)

Collaborators (6)

Carol A Lange

Sally Wheelwright

Geraldine Laven-Law

Caroline Diep, Ph.D.

Stefan Prekovic

Leila Hosseinzadeh

Make your next move.